Public health award to HK Ruokatalo
”The National Institute for Health and Welfare (THL) has granted this year’s public health award to HK Ruokatalo for the nationally significant promotion of public
3.12.2012
Cost-effectiveness of dabigatran in stroke prevention
In our recent publication, we analysed the cost-effectiveness of dabigatran in the prevention of stroke for patients with atrial fibrillation. The published analyses are based
24.8.2012
Sustained-release and immediate-release drug formulations: substitutes or different products?
Our recent publication assessed the real-life use of extended and immediate release quetiapine in patients with schizophrenia spectrum disorders and bipolar disorder in Lappeenranta. Much
20.7.2012
First Finnish Adjunct Professor in Pharmacoeconomics
Janne Martikainen, PhD (health economist and partner of ESiOR Ltd) is the first adjunct professor in the economic evaluation of pharmaceuticals in Finland.
4.6.2012
The Finnish Pharmaceutical Pricing Scheme distorts health economic assessments
We analysed the impact of pharmaceutical pricing scheme on cost-effectiveness analyses in Finland. The Finnish drug retail prices are based on computational pricing scheme that
3.1.2012
Better information – better decisions is our motto
ESiOR provides health-economic information in a form that supports decision-making. We design studies to evaluate, address and communicate the profitability and value associated with investment
28.11.2011
Fragmented source data – not enough real information?
Nowadays, diverse information sources and scientific literature are within the reach of everyone. The problem is rarely having too little information to enable decision-making. The
28.11.2011
Study requested by the US Congress
United States Government Accountability Office has published a study “Value in Health Care. Key Information for Policymakers to Assess Efforts to Improve Quality While Reducing
31.10.2011
QALY does not have a fixed price in Finland
According to the results of a Finnish survey among physicians and politicians there is no fixed, generalizable upper limit for willingness to pay (WTP) per
28.10.2011
